{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:04Z","timestamp":1793210824779,"version":"4.5.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune cerebellar ataxia (ACA) associated with anti-Homer-3 antibodies is a rare but increasingly recognized immune-mediated neurological condition. It represents a potentially treatable cause of sporadic cerebellar syndrome and may clinically mimic primarily multiple system atrophy of the cerebellar type (MSA-C), and less frequently, other atypical parkinsonian disorders. Because of the significant clinical overlap with neurodegenerative diseases, particularly MSA-C, Homer-3\u2013associated ACA may be underdiagnosed or misdiagnosed, delaying effective treatment. This narrative review synthesizes the currently available literature on anti-Homer-3 immunoglobulins, with a focus on their pathophysiological role, diagnostic utility, therapeutic response, and clinical differentiation from neurodegenerative conditions. Homer-3 is a postsynaptic scaffold protein expressed in Purkinje cells, where it plays a key role in calcium signaling through metabotropic glutamate receptor pathways. Antibodies against Homer-3 have been identified in patients with a wide range of neurological and neuropsychiatric symptoms, most commonly with subacute cerebellar ataxia. Neuroimaging in such cases frequently shows cerebellar atrophy or inflammation, and cerebrospinal fluid analysis often reveals inflammatory markers. The treatment with immunotherapy, particularly corticosteroids and intravenous immunoglobulins, which has showed encouraging results, however therapeutic outcomes can vary. The aim of this review is to collect and analyze all currently available data on anti-Homer-3\u2013associated ACA, with the goal of raising clinical awareness and emphasizing the importance of early recognition and aggressive intervention.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1660587","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:36:10Z","timestamp":1755063370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Homer-3 antibody in autoimmune cerebellar syndromes: a potentially treatable mimic of MSA-C \u2013 A review"],"prefix":"10.3389","volume":"16","author":[{"given":"Patryk","family":"Chunowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Madetko-Alster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Alster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","article-title":"\u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII","volume":"12","author":"Jarius","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-020-01132-8","article-title":"Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an international task force on immune-mediated cerebellar ataxias","volume":"19","author":"Hadjivassiliou","year":"2020","journal-title":"Cerebellum"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X-ANP-2021-0065","article-title":"Rehabilitation in patients with cerebellar ataxias","volume":"80","author":"Chien","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12311-017-0885-2","article-title":"Epidemiology of cerebellar diseases and therapeutic approaches","volume":"17","author":"Salman","year":"2018","journal-title":"Cerebellum Lond Engl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20190020","article-title":"Acute cerebellar ataxia: differential diagnosis and clinical approach","volume":"77","author":"Pedroso","year":"2019","journal-title":"Arq Neuropsiquiatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-022-01412-5","article-title":"Autoimmune cerebellar ataxia: etiology and clinical characteristics of a case series from China","volume":"22","author":"Liu","year":"2023","journal-title":"Cerebellum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11946-1","article-title":"A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution","volume":"271","author":"Kudo","year":"2024","journal-title":"J Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10741","article-title":"Multiple system atrophy - cerebellar type: clinical picture and treatment of an often-overlooked disorder","volume":"12","author":"Ortiz","year":"2020","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.19061","article-title":"Progressive supranuclear palsy with predominant cerebellar ataxia","volume":"13","author":"Ando","year":"2020","journal-title":"J Mov Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.837937","article-title":"Acute cerebellitis associated with anti-homer 3 antibodies: A rare case report and literature review","volume":"13","author":"Miao","year":"2022","journal-title":"Front Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s42466-022-00194-9","article-title":"Anti-Homer-3 antibodies in cerebrospinal fluid and serum samples from a 58-year-old woman with subacute cerebellar degeneration and diffuse breast adenocarcinoma","volume":"4","author":"Kl\u00f6tzsch","year":"2022","journal-title":"Neurol Res Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001077","article-title":"Neurological autoimmunity associated with homer-3 antibody: A case series from China","volume":"8","author":"Liu","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3492-05.2005","article-title":"Addicted to homer","volume":"25","author":"Fourgeaud","year":"2005","journal-title":"J Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cne.20116","article-title":"Differential expression of Homer family proteins in the developing mouse brain","volume":"473","author":"Shiraishi","year":"2004","journal-title":"J Comp Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.11.033","article-title":"Impaired mTORC1-dependent expression of homer-3 influences SCA1 pathophysiology","volume":"89","author":"Ruegsegger","year":"2016","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41598-019-38730-4","article-title":"Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells","volume":"9","author":"Sakai","year":"2019","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2004.08.011","article-title":"Homer-PIKE complex: a novel link between mGluRI and PI 3-kinase","volume":"27","author":"Guhan","year":"2004","journal-title":"Trends Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14802\/jmd.20040","article-title":"Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms","volume":"14","author":"Mitoma","year":"2021","journal-title":"J Mov Disord"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.1955","article-title":"Patient with homer-3 antibodies and cerebellitis","volume":"70","author":"H\u00f6ftberger","year":"2013","journal-title":"JAMA Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13010125","article-title":"Cerebrospinal fluid homer-3 autoantibodies in a patient with amnestic mild cognitive impairment","volume":"13","author":"Hansen","year":"2023","journal-title":"Brain Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000251308.79366.f9","article-title":"Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia","volume":"68","author":"Zuliani","year":"2007","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.951659","article-title":"Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies","volume":"13","author":"Wu","year":"2022","journal-title":"Front Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.929778","article-title":"Anti-homer-3 antibody encephalitis in a 10-year-old child: case report and review of the literature","volume":"13","author":"Kuang","year":"2022","journal-title":"Front Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.01.002","article-title":"Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review","volume":"330","author":"Xu","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201105","article-title":"Cerebellar swelling followed by atrophy in anti-homer-3 antibody-associated cerebellitis","volume":"99","author":"Hu","year":"2022","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29185","article-title":"HOMER-3 antibodies were not detected in two German cohorts of patients with multiple system atrophy","volume":"37","author":"Klietz","year":"2022","journal-title":"Mov Disord"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13404","article-title":"Homer-3 antibody disease: A potentially treatable MSA-C mimic","volume":"9","author":"Mulroy","year":"2022","journal-title":"Mov. Disord Clin Pract"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000001544","article-title":"Repeated and single maternal separation specifically alter microglial morphology in the prefrontal cortex and neurogenesis in the hippocampus of 15-day-old male mice","volume":"31","author":"Reshetnikov","year":"2020","journal-title":"Neuroreport"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2015.11.002","article-title":"Head tremor in essential tremor: \u201cYes-yes\u201d, \u201cno-no\u201d, or \u201cround and round\u201d","volume":"22","author":"Robakis","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14021","article-title":"Effect of thalamic versus pallidal deep brain stimulation on head tremor in dystonic and essential tremor patients-A retrospective video-blinded study","volume":"11","author":"Paschen","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"B32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3892\/etm.2021.11090","article-title":"Morphological and morphometric changes in the Purkinje cells of patients with essential tremor","volume":"23","author":"Mavroudis","year":"2022","journal-title":"Exp Ther Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025","article-title":"Clinical features of autoimmune cerebellar ataxia related to neuronal antibodies","volume":"16","author":"Cai","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12974-022-02545-4","article-title":"Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG\/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature","volume":"19","author":"Jarius","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.21037\/atm-20-2187","article-title":"Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology","volume":"11","author":"Zhang","year":"2023","journal-title":"Ann Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.10.009","article-title":"Autosomal-recessive mutations in AP3B2, adaptor-related protein complex 3 beta 2 subunit, cause an early-onset epileptic encephalopathy with optic atrophy","volume":"99","author":"Assoum","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1124\/mol.112.081802","article-title":"Activation of group I metabotropic glutamate receptors potentiates heteromeric kainate receptors","volume":"83","author":"Rojas","year":"2013","journal-title":"Mol Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.683048","article-title":"Update in autoimmune movement disorders: newly described antigen targets in autoimmune and paraneoplastic cerebellar ataxia","volume":"12","author":"Garza","year":"2021","journal-title":"Front Neurol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200041","article-title":"Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis","volume":"10","author":"Benoit","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/413098","article-title":"Cerebrospinal fluid biomarkers in spinocerebellar ataxia: A pilot study","volume":"2015","author":"Brouillette","year":"2015","journal-title":"Dis Markers"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23067","article-title":"Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status","volume":"25","author":"\u00d6z","year":"2010","journal-title":"Mov. Disord"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115070","article-title":"Evaluating glial fibrillary acidic protein and neurofilament light as potential biomarkers for spinocerebellar ataxia 7","volume":"26","author":"Hanna Al-Shaikh","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0161-6420(93)31702-1","article-title":"Olivopontocerebellar atrophy with retinal degeneration. An electroretinographic and histopathologic investigation","volume":"100","author":"To","year":"1993","journal-title":"Ophthalmology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2002.1169","article-title":"Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype","volume":"74","author":"Aleman","year":"2002","journal-title":"Exp Eye Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5156","article-title":"Prevalence of autoantibodies and the efficacy of immunotherapy for autoimmune cerebellar ataxia","volume":"55","author":"Nanri","year":"2016","journal-title":"Intern Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0551-3","article-title":"Therapeutic management of the overlapping syndromes of atypical Parkinsonism","volume":"32","author":"Giagkou","year":"2018","journal-title":"CNS Drugs"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852215","article-title":"Anti-igLON5 disease - the current state of knowledge and further perspectives","volume":"13","author":"Madetko","year":"2022","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X22666231017141636","article-title":"Inflammation, autoimmunity and neurodegenerative diseases, therapeutics and beyond","volume":"22","author":"Garmendia","year":"2024","journal-title":"Curr Neuropharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040837","article-title":"Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived human neurons","volume":"10","author":"Ryding","year":"2021","journal-title":"Cells"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration","volume":"88","author":"Landa","year":"2020","journal-title":"Ann Neurol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gr\u00fcter","year":"2022","journal-title":"Brain"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.355742","article-title":"Anti-IgLON5 disease: a novel topic beyond neuroimmunology","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regener Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00330","article-title":"Sleep disorders associated with Alzheimer\u2019s disease: A perspective","volume":"12","author":"Brzecka","year":"2018","journal-title":"Front Neurosci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00504-6","article-title":"A systematic review of clinical practice guidelines for Alzheimer\u2019s disease and strategies for future advancements","volume":"12","author":"Tahami Monfared","year":"2023","journal-title":"Neurol Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.08.018","article-title":"Tau and tauopathies","volume":"126","author":"Arendt","year":"2016","journal-title":"Brain Res Bull"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2023.0019","article-title":"Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS)","volume":"57","author":"Alster","year":"2023","journal-title":"Neurol Neurochir Pol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:36:11Z","timestamp":1755063371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":63,"alternative-id":["10.3389\/fimmu.2025.1660587"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1660587","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"article-number":"1660587"}}